Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation
Yi‐Hsin Chan(Memorial Hospital of South Bend), Gregory Y.H. Lip(Medical University of Białystok), Yung‐Hsin Yeh(Chang Gung University), Chi‐Tai Kuo(Chang Gung Memorial Hospital), Hsin‐Fu Lee(Chang Gung Memorial Hospital), Lai‐Chu See(Chang Gung University), Shang‐Hung Chang(Chang Gung University), Tze‐Fan Chao(National Yang Ming Chiao Tung University), Lung‐Sheng Wu(Chang Gung Memorial Hospital), Hui‐Tzu Tu(Chang Gung Memorial Hospital)
Cited by 119
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k
Antithrombotic Therapy for Atrial Fibrillation
|CHEST Journal|2012|919